Dynamic quotes: Off
|
Company Description (as filed with the SEC)
We are a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications. Our products improve patient outcomes by helping to prevent bloodstream infections and protect healthcare workers and patients from exposure to infectious diseases or hazardous drugs and monitoring continuous cardiac output of critical care patients. Our complete product line includes custom infusion systems, closed delivery systems for hazardous drugs, needlefree infusion connectors, catheters and cardiac monitoring systems. Our headquarters are in San Clemente, California. Our products are used in hospitals and alternate medical sites in more than 50 countries throughout the world. We categorize our products into three main product lines: Infusion Therapy, Critical Care and Oncology. Products outside of our main product lines are grouped under Other. ... More ...
Analyst Info |
|
| Annual EPS Est: | $2.8 |
| Quarterly EPS Est: | 0.65 |
| PEG Ratio: | 2.24 |
|
Mean Recommendation: View Summary / View All |
1.5 |
Data is provided by Zacks Investment Research
